Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease

Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease

Parkinson’s disease is a neurodegenerative disorder characterized by the progressive death of dopaminergic (DA) neurons in the substantia nigra (SN), which leads to a loss of the neurotransmitter dopamine in the basal ganglia. Current treatments relieve the symptoms of the disease, but none stop or...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Rafael Gonzalo-Gobernado, Diana Reimers, María José Casarejos, Lucía Calatrava Ferreras, Manuela Vallejo-Muñoz, Adriano Jiménez-Escrig, Juan José Diaz-Gil, Gonzalo M. Ulzurrun de Asanza, Eulalia Bazán
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: MDPI AG 2020-05-01
Ráidu:Brain Sciences
Fáttát:
liver growth factor
LGF
Parkinson´s disease
glial cultures
neuroprotection
6-hydroxy-dopamine
Liŋkkat:https://www.mdpi.com/2076-3425/10/5/315

Interneahtta

https://www.mdpi.com/2076-3425/10/5/315

Geahča maid